A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

After years of political debate and pressure from the pharmaceutical industry, a long-awaited reform has finally materialized ...